Belpointe Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Belpointe Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$600K	Buy	27,506 +39	+0.1%	+$1.14K	0.02%	683
2026 Q2	$994K	Hold	27,467	–	–	0.03%	500
2026 Q1	$908K	Buy	27,467 +10,729	+64%	+$454K	0.03%	493
2025 Q4	$775K	Buy	16,738 +3,048	+22%	+$128K	0.03%	526
2025 Q3	$479K	Hold	13,690	–	–	0.02%	641
2025 Q2	$405K	Buy	13,690 +30	+0.2%	+$856	0.02%	654
2025 Q1	$408K	Buy	+13,660	New	+$417K	0.02%	619
2023 Q2	–	Sell	-1,144	Closed	-$27.4K	–	1111
2023 Q1	$27.4K	Buy	1,144 +228	+25%	+$6.05K	﹤0.01%	2115
2022 Q4	$21.3K	Buy	+916	New	+$18.5K	﹤0.01%	2140

Other funds holding COLL

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $2.95B AUM 28.43% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Belpointe Asset Management's COLL Position: Q3 2026 in Review

Belpointe Asset Management increased its Collegium Pharmaceutical (COLL) stake by 0.14% in Q3 2026, buying an estimated $1.14K and bringing the position to 27,506 shares worth $600K. The position accounts for 0.02% of the portfolio, ranked #683.

Belpointe Asset Management first reported a position in COLL in Q4 2022 and has held it in 9 quarters since. The position peaked at $994K in Q2 2026. 118 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

Belpointe Asset Management held 27,506 shares of Collegium Pharmaceutical worth $600K as of Q3 2026.
Belpointe Asset Management bought 39 Collegium Pharmaceutical shares in Q3 2026, an estimated $1.14K.
Collegium Pharmaceutical made up 0.02% of Belpointe Asset Management's portfolio in Q3 2026, its #683 holding.
Belpointe Asset Management first reported a position in Collegium Pharmaceutical in Q4 2022 and has held it in 9 quarters since.
Belpointe Asset Management's Collegium Pharmaceutical position peaked at $994K in Q2 2026.
118 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Belpointe Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.